Income Statement
DIANTHUS THERAPEUTICS, INC. /DE/
DNTH
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
2.04 | 6.24 | 2.83 | - | - | - | 0.00 | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
2.04 | 6.24 | 2.83 | - | - | - | - | - |
|
Operating Expenses
|
179.97 | 108.10 | 51.00 | 80.90 | 74.69 | 78.70 | 82.97 | 59.96 |
|
Research & Development
|
191.00 | 83.11 | 32.84 | 55.14 | 46.77 | 50.62 | 59.21 | 41.34 |
|
Selling, General & Administrative
|
34.33 | 24.99 | 18.16 | 25.76 | 27.93 | 28.09 | 23.76 | 18.62 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-177.93 | -101.86 | -48.17 | -80.90 | -74.69 | -78.70 | -82.97 | -59.96 |
|
Non-Operating Income
|
15.60 | 16.90 | 4.62 | - | - | - | - | 2.45 |
|
Interest Income
|
16.12 | 17.37 | 4.76 | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
-0.97 | -0.55 | -0.06 | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-162.34 | -84.97 | -43.56 | -76.46 | -71.14 | -74.94 | -76.77 | -57.52 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-177.93 | -101.86 | -48.17 | -78.98 | -72.67 | -76.70 | -81.13 | -59.09 |
|
Earnings Per Share (Basic)
|
-4.20 | -2.55 | -8.45 | -1.29 | -1.29 | - | - | - |
|
Diluted EPS
|
-4.20 | -2.55 | -8.45 | -1.29 | -1.29 | - | - | - |
|
Weighted Average Shares
|
38.62 | 33.31 | 5.15 | 59.37 | 54.95 | - | - | - |
|
Diluted Weighted Avg Shares
|
38.62 | 33.31 | 5.15 | 59.37 | 54.95 | - | - | - |
|
Comprehensive Income
|
-161.95 | -84.91 | -43.35 | -76.61 | -71.14 | -74.97 | -76.75 | -57.52 |